Improvement of glucose and lipid profile status with Aloe vera in pre-diabetic subjects: A randomized controlled-trial

Journal of Diabetes and Metabolic Disorders

Volumn 14, Issue 1, 2015, Pages

  Alinejad Mofrad, Samaneh ^a   Foadoddini, Mohsen ^b   Saadatjoo, Seyed A ^a   Shayesteh, Majid ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aloe vera; Fast blood glucose; Herbal medicine; Lipid profile; Pre diabetis

Indexed keywords

ALOE VERA EXTRACT; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ALOE VERA; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

EID: 84927765608     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-015-0137-2     Document Type: Article

References (29)

1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006, 29(6):1263-8. 10.2337/dc06-0062, 16732006.
2. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379(9833):2279-90. 10.1016/S0140-6736(12)60283-9, 22683128.
3. Chen G, Liu C, Yao J, Jiang Q, Chen N, Huang H, et al. Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China. Metabolism 2010, 59(12):1823-32. 10.1016/j.metabol.2010.06.009, 20655552.
4. Association AD. Economic costs of diabetes in the US in 2007. Diabetes Care 2008, 31(3):596-615. 10.2337/dc08-9017.
5. Cao H, Ren M, Guo L, Shang H, Zhang J, Song Y, et al. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial. Trials 2010, 11(1):27. 10.1186/1745-6215-11-27, 20214831.
6. al-Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabet Res 1991, 18(4):163.
7. Yagi A, Hegazy S, Kabbash A, Wahab EA-E. Possible hypoglycemic effect of Aloe vera L. high molecular weight fractions on type 2 diabetic patients. Saudi Pharm J 2009, 17(3):209-15. 10.1016/j.jsps.2009.08.007, 23964163.
8. Sharrif Moghaddasi M, Sandeep KV. Aloe vera their chemicals composition and applications: a review. Int J Biol Med Res 2011, 2(1):466-71.
9. Rajasekaran S, Aathishsekar D. Therapeutic evaluation of Aloe vera leaf gel extract on glycoprotein components in rats with streptozotocin diabetes. J Pharmacol Toxicol 2007, 2(4):380-5. 10.3923/jpt.2007.380.385.
10. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004, 27(5):694-8. 10.1248/bpb.27.694, 15133247.
11. Parihar M, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera . J Clin Neurosci 2004, 11(4):397-402. 10.1016/j.jocn.2003.09.008, 15080956.
12. Agarwal O. Prevention of atheromatous heart disease. Angiology 1985, 36(8):485-92. 10.1177/000331978503600801, 2864002.
13. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996, 3(3):245-8. 10.1016/S0944-7113(96)80061-4, 23195078.
14. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord 2013, 11(1):35-40. 10.1089/met.2012.0066, 23035844.
15. Fallah HH, Kianbakht S, Hajiaghaee R, Afkhami AM, Bonakdaran A, Hashem DF. Aloe vera leaf gel in treatment of advanced type 2 diabetes mellitus needing insulin therapy: a randomized double-blind placebo-controlled clinical trial. J Med Plants 2012, 11(43):19-27.
16. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-5. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112(17):2735-52. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
18. Rajasekaran S, Sriram N, Arulselvan P, Subramanian S. Effect of Aloe vera leaf gel extract on membrane bound phosphatases and lysosomal hydrolases in rats with streptozotocin diabetes. Pharmazie 2007, 62(3):221-5. 17416200.
19. Kim K, Kim H, Kwon J, Lee S, Kong H, Im S-A, et al. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine 2009, 16(9):856-63. 10.1016/j.phymed.2009.02.014, 19303272.
20. Koo M. Aloe vera: Antiulcer and antidiabetic effects. Phytother Res 1994, 8(8):461-4. 10.1002/ptr.2650080805.
21. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003, 26(4):1277-94. 10.2337/diacare.26.4.1277, 12663610.
22. Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 2006, 29(7):1418-22. 10.1248/bpb.29.1418, 16819181.
23. Okyar A, Can A, Akev N, Baktir G, Sütlüpinar N. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res 2001, 15(2):157-61. 10.1002/ptr.719, 11268118.
24. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S. Beneficial effects of Aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 2006, 33(3):232-7. 10.1111/j.1440-1681.2006.04351.x, 16487267.
25. Kim K, Yun SH, Choi BY, Kim MK. Cross-sectional relationship between dietary carbohydrate, glycaemic index, glycaemic load and risk of the metabolic syndrome in a Korean population. Br J Nutr 2008, 100(03):576-84. 10.1017/S0007114508904372, 18328117.
26. Kamal-Eldin A, Moazzami A. Plant sterols and stanols as cholesterol-lowering ingredients in functional foods. Recent Pat Food Nutr Agric 2009, 1(1):1-14. 10.2174/2212798410901010001, 20653521.
27. Joshi SC, Gajraj A. Induction of hypocholesterolemia associated with testicular dysfunction by Aloe barbedensis in Albino Rats. Pharmacologyonline 2006, 3:1-8.
28. Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, et al. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: Investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J Ethnopharmacol 2006, 103(3):468-77. 10.1016/j.jep.2005.10.034, 16406411.
29. Misawa E, Tanaka M, Nomaguchi K, Nabeshima K, Yamada M, Toida T, et al. Oral ingestion of Aloe vera phytosterols alters hepatic gene expression profiles and ameliorates obesity-associated metabolic disorders in Zucker diabetic fatty rats. J Agric Food Chem 2012, 60(11):2799-806. 10.1021/jf204465j, 22352711.